Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Index- P/E29.61 EPS (ttm)0.41 Insider Own1.49% Shs Outstand494.33M Perf Week-3.20%
Market Cap5.98B Forward P/E13.30 EPS next Y0.91 Insider Trans1.43% Shs Float486.97M Perf Month-14.73%
Income205.00M PEG2.96 EPS next Q0.15 Inst Own98.02% Short Float3.20% Perf Quarter-16.72%
Sales4.45B P/S1.34 EPS this Y2.89% Inst Trans-0.22% Short Ratio3.26 Perf Half Y-32.89%
Book/sh13.20 P/B0.92 EPS next Y-0.61% ROA1.48% Short Interest15.58M Perf Year-11.42%
Cash/sh0.99 P/C12.21 EPS next 5Y10.00% ROE3.24% 52W Range11.40 - 18.80 Perf YTD-18.79%
Dividend Est.- P/FCF15.74 EPS past 5Y- ROI1.89% 52W High-35.64% Beta1.41
Dividend TTM- Quick Ratio1.31 Sales past 5Y9.00% Gross Margin42.68% 52W Low6.14% ATR (14)0.47
Dividend Ex-Date- Current Ratio2.55 EPS Y/Y TTM117.83% Oper. Margin5.68% RSI (14)37.53 Volatility4.08% 3.51%
Employees9800 Debt/Eq0.67 Sales Y/Y TTM1.92% Profit Margin4.60% Recom1.88 Target Price18.08
Option/ShortYes / Yes LT Debt/Eq0.66 EPS Q/Q132.88% Payout- Rel Volume1.75 Prev Close12.59
Sales Surprise-0.61% EPS Surprise6.21% Sales Q/Q-3.56% EarningsNov 07 BMO Avg Volume4.77M Price12.10
SMA20-6.62% SMA50-8.69% SMA200-17.25% Trades Volume8,366,974 Change-3.89%
Date Action Analyst Rating Change Price Target Change
Dec-09-24Initiated UBS Buy $18
Dec-02-24Initiated Leerink Partners Market Perform $14
Sep-19-24Downgrade Morgan Stanley Overweight → Equal-Weight $17 → $15
Jan-05-24Upgrade Stifel Hold → Buy $13 → $20
Dec-19-23Initiated Jefferies Buy $17
Dec-15-23Upgrade Morgan Stanley Equal-Weight → Overweight $16
Dec-07-23Initiated Exane BNP Paribas Outperform $18
Apr-20-23Upgrade Barclays Equal Weight → Overweight $14
Aug-18-22Downgrade Morgan Stanley Overweight → Equal-Weight $37 → $22
Aug-16-22Downgrade JP Morgan Overweight → Neutral $28 → $24
Dec-01-24 09:08AM
Nov-29-24 12:18PM
Nov-27-24 01:45PM
Nov-26-24 07:22AM
04:31AM
08:45AM Loading…
Nov-25-24 08:45AM
08:00AM
Nov-24-24 11:33AM
Nov-23-24 07:23AM
Nov-21-24 10:46AM
Nov-20-24 08:53AM
Nov-18-24 02:52PM
Nov-15-24 11:30AM
Nov-14-24 03:15PM
Nov-13-24 01:39PM
07:20PM Loading…
Nov-12-24 07:20PM
08:33AM
05:45AM
Nov-11-24 04:02PM
Nov-08-24 04:03AM
02:09AM
02:03AM
Nov-07-24 04:30PM
03:28PM
12:41PM
09:30AM
08:52AM
07:35AM
06:27AM
Nov-05-24 07:38AM
03:51PM Loading…
Nov-04-24 03:51PM
09:16AM
Nov-01-24 05:45AM
Oct-31-24 01:42PM
10:01AM
Oct-30-24 11:46AM
Oct-28-24 07:17PM
Oct-25-24 09:56AM
Oct-24-24 02:29PM
Oct-23-24 10:16AM
Oct-22-24 10:42AM
Oct-21-24 06:12PM
Oct-17-24 12:14PM
12:10PM
Oct-16-24 11:21AM
08:54AM
Oct-11-24 09:14AM
Oct-10-24 08:00AM
Oct-09-24 11:23AM
Oct-08-24 08:43PM
Oct-07-24 04:19PM
Sep-20-24 10:35AM
Sep-19-24 03:08PM
01:42PM
12:50PM
Sep-13-24 07:30AM
Aug-28-24 06:30AM
Aug-20-24 06:27AM
Aug-15-24 08:27AM
Aug-13-24 01:49PM
Aug-09-24 02:35AM
Aug-08-24 03:45PM
09:30AM
07:35AM
06:28AM
Aug-06-24 01:00PM
Aug-05-24 09:16AM
Aug-01-24 03:14PM
10:01AM
Jul-30-24 08:27AM
Jul-25-24 01:18PM
Jul-22-24 02:42PM
10:18AM
Jul-18-24 08:00AM
Jul-15-24 03:20PM
Jul-12-24 12:04PM
Jul-10-24 03:22PM
01:23PM
Jul-09-24 08:30AM
08:28AM
Jul-08-24 02:09PM
Jun-27-24 04:12PM
06:27AM
Jun-07-24 12:00PM
Jun-06-24 08:00AM
May-28-24 07:30PM
06:27AM
May-24-24 02:39AM
May-23-24 04:03PM
May-21-24 08:00AM
May-13-24 09:17AM
May-09-24 08:54PM
11:33AM
10:26AM
09:44AM
07:43AM
03:05AM
May-08-24 04:04PM
02:00PM
12:32PM
Elanco Animal Health, Inc. innovates, develops, manufactures, and markets products for pets and farm animals. It offers products through the following four categories: Companion Animal Disease Prevention, Companion Animal Therapeutics, Food Animal Future Protein & Health, and Food Animal Ruminants & Swine. The Companion Animal Disease Prevention category engages in the broadest parasiticide portfolios in the companion animal sector based on indications, species and formulations, with products that protect pets from worms, fleas and ticks. The Companion Animal Therapeutics category provides the details of a broad pain and osteoarthritis portfolio across species, modes of action, indications and disease stages. The Food Animal Future Protein & Health category includes vaccines, nutritional enzymes and animal-only antibiotics, serves the growing demand for protein and includes innovative products in poultry and aquaculture production, where demand for animal health products is outpacing overall industry growth. It also focuses on developing functional nutritional health products that promote food animal health, including enzymes, probiotics and prebiotics. The Food Animal Ruminants & Swine category develops animal food products used in ruminant and swine production. The company was founded in 1954 and is headquartered in Greenfield, IN.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Harrington Michael JDirectorAug 22 '24Buy14.853,50051,97481,094Aug 26 05:05 PM
Simmons Jeffrey NPRESIDENT, CEO AND DIRECTORAug 12 '24Buy13.01100,0001,300,610145,000Aug 13 09:04 AM
DOYLE WILLIAM FDirectorMay 21 '24Buy16.9815,000254,70076,330May 23 04:33 PM
DOYLE WILLIAM FDirectorMar 08 '24Buy16.3015,000244,50061,330Mar 12 04:32 PM
Harrington Michael JDirectorMar 08 '24Buy16.293,10050,49477,594Mar 12 04:30 PM
HOOVER R DAVIDDirectorMar 06 '24Buy16.1420,000322,808185,000Mar 08 05:09 PM